Why BofA Sees Strong Upside for Doximity (DOCS)

Doximity (NYSE:DOCS) is one of the most promising mid-cap healthcare stocks under $50. On December 16, Bank of America analyst Allen Lutz reiterated his bullish stance on Doximity (NYSE:DOCS). He assigned a Buy rating to the stock with a $82 price target. This implies a highly attractive 88% upside potential for investors within the prevailing trading range. Lutz attributed such upside to accelerating growth within the healthcare provider (HCP) budgets, as Doximity (NYSE:DOCS) has also been raising its ...